Portugal, Aug. 25 -- Portugal based NOVARTIS FARMA PRODUTOS FARMACEUTICOS, SA has secured contract from Servico De Saude Da Regiao Autonoma Da Madeira, Epe-Ram for Bead20250374 - Acquisition Of Tyrosinacinases Inhibitors - Ruxolitinib - 2Nd Semester. The value of the contract is worth 11461359 EUR.
Published by HT Digital Content Services with permission from Pivotal Sources....